Iovance Biotherapeutics, Inc. · NASDAQ:IOVA
Bilinsky Igor exercised options for 8,789 Iovance Biotherapeutics, Inc. shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 3, 2026
On Sep 1, 2026, Bilinsky Igor (Chief Operating Officer) exercised options for 8,789 Iovance Biotherapeutics, Inc. shares, leaving 138,237 shares. Filed Sep 3, 2026 (Form 4).
- Options exercised
- 8,789 shares
- Holding after
- 138,237 shares
- Trading plan
- No
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Option exercise | 8,789 | 142,709 | Direct | |
| Sep 1, 2026 | Common Stock | Shares withheld for tax | 4,472 | US$8.28 | 138,237 | Direct |
Source
Related
- Iovance Biotherapeutics, Inc.
- Bilinsky Igor
- Iovance Biotherapeutics, Inc. shareholders
- Form 4 · Bilinsky Igor · Sep 10, 2026
- Form 4 · Bilinsky Igor · Jun 9, 2026
- Form 4 · Bilinsky Igor · Jun 3, 2026
- Form 4 · Vogt Frederick G · Sep 10, 2026
- Form 4 · Puri Raj K. · Sep 10, 2026
- Form 4 · Vogt Frederick G · Sep 3, 2026
- Form 4 · Puri Raj K. · Sep 3, 2026
- Form 4 · Kirby Daniel Gordon · Aug 12, 2026